What is Calyxt, Inc.'s stock symbol?

Our stock is traded on the Nasdaq under the symbol CLXT.

When was Calyxt, Inc. incorporated?


When did Calyxt, Inc. become a public company?

July 25, 2017

How did the Company go public?

Prior to the Company’s Initial Public Offering in July 2017, Calyxt was a wholly-owned subsidiary of Cellectis, a French biopharmaceutical company. Calyxt then completed its $56.0 million Initial Public Offering at $8.00 per share with Citigroup, Jefferies and Wells Fargo Securities acting as joint book-running managers and BMO Capital Markets and Ladenburg Thalmann acting as co-managers. In the Company’s $54.0 million follow-on offering at $15.00 per share in May 2018, Citigroup, Goldman Sachs and Jefferies acted as book-running managers, with Wells Fargo Securities acting as lead manager and BMO Capital Markets acting as co-manager.

Where is Calyxt, Inc. located?

2800 Mount Ridge Road
Roseville, MN 55113

When is Calyxt, Inc.'s fiscal year end?

December 31st

Who is Calyxt, Inc.'s transfer agent?

Broadridge Corporate Issuer Solutions, Inc.
1155 Long Island Avenue
Edgewood, NY 11717
T: 1-877-830-4932

Who is Calyxt, Inc.'s auditor?

Ernst & Young LLP
220 South Sixth Street
Suite 1400
Minneapolis, MN 55403
T: 612-371-6984